Amarin Pharmaceuticals Ireland Ltd
General
Total Cases22
Active Cases1
Patents71
--
--
--
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/02/24 | Official Transcript of Motion to Strike held on 8/29/22 before Judge Jennifer Hall. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/23/2024. Redacted Transcript Deadline set for 3/4/2024. Release of Transcript Restriction set for 5/2/2024. (Warner, Deanna) (Entered: 02/02/2024) | |
| 09/20/23 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,700,537; US 8,642,077; US 10,568,861. (Attachments: # 1 Final Judgment (D.I. 144), # 2 Order (D.I. 154))(nms) (Entered: 09/20/2023) | |
| 09/19/23 | CASE CLOSED per entry of D.I. 154 . (nms) (Entered: 09/19/2023) | |
| 02/06/23 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Association for Accessible Medicines. (Schladweiler, Benjamin) (Entered: 02/06/2023) | |
| 02/02/23 | DEFICIENCY NOTICE issued by the Court to Association for Accessible Medicines: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) (Entered: 02/02/2023) | |
| 01/03/23 | SO ORDERED Granting 153 Joint Stipulation of Dismissal and Order of Dismissal (*Party Health Net, LLC terminated). Signed by Judge Richard G. Andrews on 1/3/2023. (nms) (Entered: 01/03/2023) | |
| 01/03/23 | STIPULATION and Order of Dismissal, by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Mochida Pharmaceutical Co.,Ltd.. (Oakes, Robert) Modified on 1/3/2023 (nms). (Entered: 01/03/2023) | |
| 12/13/22 | SO ORDERED, granting 151 Stipulation and Order to Extend Stay to January 3, 2023. Signed by Judge Jennifer L. Hall on 12/13/2022. (ceg) (Entered: 12/13/2022) | |
| 12/12/22 | STIPULATION and Proposed Order to Extend Stay by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Mochida Pharmaceutical Co.,Ltd.. (Oakes, Robert) (Entered: 12/12/2022) | |
| 12/12/22 | JOINT Status Report, by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Mochida Pharmaceutical Co.,Ltd.. (Oakes, Robert) Modified on 12/13/2022 (nms). (Entered: 12/12/2022) |